High Doses of Flovent Fail To Help Treat Severe Asthma In Children: Study
A new study warns that high doses of inhalers do not provide additional benefits to children with asthma.…
«
»
A new study warns that high doses of inhalers do not provide additional benefits to children with asthma.…
GlaxoSmithKline has issued a pharmacy level recall for about 600,000 Ventolin HFA 200D albuterol inhalers after users reported the medication was leaking into the packaging, suggesting that the devices may not administer the full number of doses indicated by the dose counter.…
Ads for Brovana inhalers are misleading and downplay the side effects, the FDA has warned the company.…
The FDA is warning of severe adverse reactions from Asthmanefrin, which has only been on the market a year.…
Primatene Mist, Armstrong Pharmaceutical Inc.’s over-the-counter asthma inhaler, will no longer be available after December 31, 2011, as part of an international treaty to preserve the ozone layer. …
Potential side effects of Spiriva mist inhalers, which are not yet approved for sale in the United States, could increase the risk of death by more than 50%, according to a new study by Johns Hopkins researchers. …
Federal drug regulators have ordered that new studies be done to examine potential safety problems with a number of asthma drugs, including Advair, Symbicort, Dulera and Foradil. …
A nationwide study of births in Denmark has ruled out a potential link between corticosteroids used to control asthma in pregnant women and a risk of oral cleft birth defects, such as cleft palate and cleft lip.…
Several asthma inhalers will be gradually phased out over the course of the year to comply with international agreements designed to protect the ozone layer. …
The FDA has concluded their investigation into potential side effects of Spiriva HandiHaler, and the agency indicates that they did not find a link between the chronic pulmonary obstructive disease (COPD) inhaler and an increased risk of heart attack, stroke or death.…